- £821.36m
- £821.34m
- -£39.79m
- 51
- 76
- 61
- 71
REG - Syncona Limited - Freeline presents data in haemophilia B
AnnouncementREG - Syncona Limited - Holding(s) in Company
AnnouncementREG - Syncona Limited - Publication of 2022 Annual Report & Notice of AGM
AnnouncementREG - Syncona Limited - Director Declaration
AnnouncementREG - Syncona Limited - Final Results
AnnouncementREG - Syncona Limited - Autolus presents clinical data updates at EHA
AnnouncementREG - Syncona Limited - Holding(s) in Company
AnnouncementREG - Syncona Limited - Notice of Results
AnnouncementREG - Syncona Limited - Syncona invests in $56 million SwanBio Series B
AnnouncementREG - Syncona Limited - Autolus to present clinical data at EHA Congress
AnnouncementREG - Syncona Limited - Freeline reports Q1 2022 Financial Results
AnnouncementREG - Syncona Limited - Achilles reports Q1 2022 Financial Results
AnnouncementREG - Syncona Limited - Autolus Reports Q1 2022 Financial Results
AnnouncementREG - Syncona Limited - Syncona invests in £75.5 million OMass Series B
AnnouncementREG - Syncona Limited - Anaveon announces initial clinical data
AnnouncementREG - Syncona Limited - Director/PDMR Shareholding
AnnouncementREG - Syncona Limited - Freeline reports Full Year 2021 Financial Results
AnnouncementREG - Syncona Limited - Holding(s) in Company
AnnouncementREG - Syncona Limited - Freeline enters into ADS purchase agreement
Announcement